52 Participants Needed

Virtual Reality Cognitive Remediation for Psychosis

SG
Overseen BySynthia Guimond, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: The Royal Ottawa Mental Health Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a virtual reality program designed to help people with psychosis improve their thinking and social skills. The program uses virtual reality to make it easier for participants to practice and apply these skills in everyday life. The trial includes two groups: one experiences the Virtual Reality Cognitive Remediation Program, while the other receives a different active treatment, called the Active Control, for comparison. It suits those diagnosed with a psychotic disorder who have stable symptoms and have not recently changed medications. As an unphased trial, this study offers a unique opportunity to contribute to innovative research and potentially benefit from cutting-edge virtual reality therapy.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you must not have changed your medication dosage, started a new medication, or stopped a medication in the month before joining the trial.

What prior data suggests that this virtual reality cognitive remediation program is safe for individuals with psychosis?

Research has shown that virtual reality for cognitive therapy is safe for people with psychotic disorders. Studies have found that this therapy is generally well-tolerated, with most people not experiencing serious side effects. For example, one study found that participants using virtual reality to enhance their thinking and social skills did not report major problems. Instead, they noticed improvements in their cognitive abilities and daily life.

Overall, the evidence suggests that virtual reality cognitive therapy safely aids in improving thinking and social skills in those with psychotic disorders. For those considering joining a clinical trial for this treatment, the safety data is reassuring.12345

Why are researchers excited about this trial?

Researchers are excited about the Virtual Reality Cognitive Remediation Program for psychosis because it offers a unique approach compared to standard treatments like medication and traditional therapy. Unlike typical methods that mainly focus on managing symptoms, this program uses virtual reality technology to actively engage patients in cognitive exercises. This interactive method aims to improve cognitive functions such as memory and attention, which are often impaired in psychosis, potentially leading to better overall outcomes for patients. By providing an immersive and engaging experience, it might enhance patient motivation and adherence to therapy, offering a promising complement to existing treatment options.

What evidence suggests that this trial's treatments could be effective for psychosis?

Research shows that virtual reality can enhance thinking and social skills in people with psychotic disorders. In this trial, participants in the Virtual Reality Cognitive Remediation Program arm will engage in cognitive exercises using virtual reality. Studies have found that these exercises lead to better thinking skills and social interactions. One study found that virtual reality led to greater improvements in overall thinking skills compared to traditional methods. The immersive experience of virtual reality helps people apply these skills more effectively in real-life situations. This approach shows promise for improving daily life for those living with psychosis. Meanwhile, participants in the Active Control arm will receive a different program for comparison.14567

Who Is on the Research Team?

SG

Synthia Guimond, PhD

Principal Investigator

Royal Ottawa Mental Health Centre

Are You a Good Fit for This Trial?

This trial is for people aged 20-55 with a psychosis-spectrum disorder like schizophrenia, who speak English and have had stable medication doses for the past month. It's not suitable for those with cognitive impairments from other conditions, no smartphone, seizure history, severe eye/ear/balance issues, significant brain injury, intellectual disability or recent substance abuse.

Inclusion Criteria

Clinically stable with a total Positive And Negative Severity Symptoms score between 30 - 95
I have been diagnosed with a psychosis-spectrum disorder.
I am between 20 and 55 years old.
See 1 more

Exclusion Criteria

I have a history of seizures or epilepsy.
Vision conditions that cannot be corrected with contact lenses or glasses that can fit in the virtual reality goggles
Intellectual disability or a score below 70 on the Wechsler Abbreviated Scale of Intelligence
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
2 visits (in-person)

Treatment

Participants undergo a six-week cognitive remediation program using virtual reality, with exercises and discussions.

6 weeks
12 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments at 1-week and 3-months post-intervention.

3 months
2 visits (in-person)

Long-term Follow-up

Participants complete additional assessments at 6-months post-intervention to evaluate long-term effects.

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Active Control
  • Virtual Reality Cognitive Remediation Program
Trial Overview The study tests a virtual reality program designed to improve thinking and social skills in individuals with psychotic disorders. Participants will use VR as part of cognitive remediation therapy to see if it helps them better manage daily activities and relationships.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive RemediationExperimental Treatment1 Intervention
Group II: Active ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Royal Ottawa Mental Health Centre

Lead Sponsor

Trials
24
Recruited
2,300+

Fonds de la Recherche en Santé du Québec

Collaborator

Trials
84
Recruited
46,700+

The Royal's Institute of Mental Health Research

Collaborator

Trials
8
Recruited
1,300+

Published Research Related to This Trial

Participants with psychosis reported significant improvements in managing agoraphobic avoidance after using gameChange VR therapy, particularly those with severe avoidance, highlighting its efficacy as a therapeutic tool.
The immersive VR scenarios allowed users to confront their anxieties in a safe environment, enabling them to learn new coping strategies and gradually apply these skills in real-world situations, suggesting a promising mechanism for anxiety reduction.
A Safe Place to Learn: Peer Research Qualitative Investigation of gameChange Virtual Reality Therapy.Bond, J., Kenny, A., Pinfold, V., et al.[2023]
Cognitive Remediation (CR) therapy significantly improved non-verbal memory and functioning in 46 participants with psychosis, suggesting its efficacy in addressing cognitive difficulties associated with the condition.
The study highlights the importance of therapeutic alliance, as it was linked to improvements in functioning and cognitive outcomes, indicating that the relationship between the therapist and the patient plays a crucial role in the effectiveness of CR.
The nuts and bolts of Cognitive Remediation: Exploring how different training components relate to cognitive and functional gains.Cella, M., Wykes, T.[2022]
A study involving 16 adolescents aged 13 to 18 years with early onset psychosis found that VR-assisted cognitive behavioral therapy (CBTp) was well-accepted, with 14 out of 16 participants expressing positive expectations about using VR for therapy.
The use of VR in therapy provided a less threatening environment for adolescents to confront their fears, suggesting that VR could be a valuable tool in treating early onset psychosis and enhancing engagement in therapy.
Views of young people with psychosis on using virtual reality assisted therapy. A qualitative study.Holgersen, G., Nordgreen, T., Ten Velden Hegelstad, W., et al.[2023]

Citations

Cognitive Remediation for Psychosis in Virtual Reality ...Cognitive remediation improves cognition and psychosocial functioning in individuals with psychotic disorders. The use of virtual reality ...
Effect of immersive virtual reality-based cognitive remediation ...We will examine the effect of a 4-week, intensive virtual reality-based cognitive remediation programme involving daily life challenges on cognition and daily ...
Effect of Immersive Virtual Reality-based Cognitive ...The investigators hypothesize that VR-based cognitive remediation vs. a VR control treatment has a beneficial effect on cognition after four-weeks treatment ...
Virtual reality interventions for cognitive remediation in ...Their work indicated that VR intervention resulted in significant improvement in the global cognitive skills assessed with Cognition Assessment in Virtual ...
5.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38268043/
Effect of immersive virtual reality-based cognitive ...We will examine the effect of a 4-week, intensive virtual reality-based cognitive remediation programme involving daily life challenges on cognition and daily ...
Virtual reality interventions for cognitive remediation in ...Their work indicated that VR intervention resulted in significant improvement in the global cognitive skills assessed with Cognition Assessment ...
Effect of immersive virtual reality-based cognitive ...We will examine the effect of a 4-week, intensive virtual reality-based cognitive remediation programme involving daily life challenges on cognition and daily ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security